Effects of golimumab, an anti-tumour necrosis factor-α human monoclonal antibody, on lipids and markers of inflammation

OBJECTIVES: To assess the effect of golimumab, with or without methotrexate (MTX), on serum lipids and inflammatory markers of cardiovascular disease (CVD) in patients with rheumatoid arthritis (RA) in two phase 3, randomised, placebo-controlled trials (GO-BEFORE and GO-FORWARD). METHODS: Patients i...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Kirkham, Bruce W, Wasko, Mary Chester, Hsia, Elizabeth C, Fleischmann, Roy M, Genovese, Mark C, Matteson, Eric L, Liu, Hongjuan, Rahman, Mahboob U
Format: Artigo
Langue:Inglês
Publié: BMJ Publishing Group 2014
Sujets:
Clinical and Epidemiological Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3888596/
https://ncbi.nlm.nih.gov/pubmed/23300117
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2012-202089
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires